Abstract:Our findings provide an efficient combination strategy for increasing clinically important daptomycin production by enhancing aspartate precursor supply, abolishing by‐product red pigment production, engineering daptomycin biosynthetic gene cluster (BGC) by promoter replacement, and duplicating the engineered daptomycin BGC in Streptomyces roseosporus wild‐type strain. We finally obtained a maximal DAP titre of 350.7 μg/mL, representing the highest reported titre in shake‐flask fermentation. Such strategies can be readily applied in the overproduction of other antibiotics using aspartate as a precursor. Daptomycin (DAP), a novel cyclic lipopeptide antibiotic produced by Streptomyces roseosporus, is clinically important for treatment of infections caused by multidrug‐resistant Gram‐positive pathogens, but the low yield hampers its large‐scale industrial production. Here, we describe a combination metabolic engineering strategy for constructing a DAP high‐yielding strain. Initially, we enhanced aspartate (Asp) precursor supply in S. roseosporus wild‐type (WT) strain by separately inhibiting Asp degradation and competitive pathway genes using CRISPRi and overexpressing Asp synthetic pathway genes using strong promoter kasOp*. The resulting strains all showed increased DAP titre. Combined inhibition of acsA4, pta, pyrB, and pyrC increased DAP titre to 167.4 μg/mL (73.5% higher than WT value). Co‐overexpression of aspC, gdhA, ppc, and ecaA led to DAP titre 168 μg/mL (75.7% higher than WT value). Concurrently, we constructed a chassis strain favourable for DAP production by abolishing by‐product production (i.e., deleting a 21.1 kb region of the red pigment biosynthetic gene cluster (BGC)) and engineering the DAP BGC (i.e., replacing its native dptEp with kasOp*). Titre for the resulting chassis strain reached 185.8 μg/mL. Application of our Asp precursor supply strategies to the chassis strain further increased DAP titre to 302 μg/mL (2.1‐fold higher than WT value). Subsequently, we cloned the engineered DAP BGC and duplicated it in the chassis strain, leading to DAP titre 274.6 μg/mL. The above strategies, in combination, resulted in maximal DAP titre 350.7 μg/mL (2.6‐fold higher than WT value), representing the highest reported DAP titre in shake‐flask fermentation. These findings provide an efficient combination strategy for increasing DAP production and can also be readily applied in the overproduction of other Asp‐related antibiotics.

Screening of Sodium Caprate Resistance Strains for Daptomycin Production and Medium Optimization by Response Surface Methodology

Optimization of fermentation conditions for production of a novel antifungal metabolite by response surface methodology

Strain Improvement of Streptomyces Roseosporus for Daptomycin Production by Rational Screening of He–Ne Laser and NTG Induced Mutants and Kinetic Modeling

Daptomycin Antibiotic Production Processes in Fed-Batch Fermentation by Streptomyces Roseosporus NRRL11379 with Precursor Effect and Medium Optimization.

Daptomycin production enhancement by ARTP mutagenesis and fermentation optimization in Streptomyces roseosporus

Screening of High Daptomycin-producing Strain by He-Ne Laser Irradiation and Streptomycin Resistance Screening Method

60Co Γ-Irradiation MUTATION INDUCTION FOR SCREENING OF AVILAMYCIN STRAINS WITH HIGH PRODUCTIVITY AND ITS CULTURE MEDIUM OPTIMIZATION

Improving the Yield and Quality of Daptomycin in Streptomyces Roseosporus by Multilevel Metabolic Engineering

Optimization of Culture Conditions for Production of Cis-Epoxysuccinic Acid Hydrolase Using Response Surface Methodology

Optimization of Medium Constituents for Ε-Poly-l-lysine Fermentation with Response Surface Methodology.

Metabolic Flux Analysis and Principal Nodes Identification for Daptomycin Production Improvement by Streptomyces Roseosporus

Optimizing the Medium Compositions for Accumulation of the Novel Fr-008/Candicidin Derivatives Cs101 by A Mutant of Streptomyces Sp Using Statistical Experimental Methods

Metabolic engineering of Streptomyces roseosporus for increased production of clinically important antibiotic daptomycin

Statistical Optimization of Medium Components to Improve the Antibiotic Activity of Streptomyces Sp 19G-317

Screening of High Yield Propionic Acid Producing Strain and Optimization of Its Fermentation Medium

Response Surface Methodology to Optimize Fermentation Technology of Brevibacillus brevis ch2-22

A novel strategy of gene screen based on multi-omics in Streptomyces roseosporus

Kinetic Analysis and Modeling of Daptomycin Batch Fermentation by Streptomyces Roseosporus

Improved Neomycin Sulfate Potency in Streptomyces fradiae Using Atmospheric and Room Temperature Plasma (ARTP) Mutagenesis and Fermentation Medium Optimization

Enhancement of Daptomycin Production in Streptomyces Roseosporus LC-51 by Manipulation of Cofactors Concentration in the Fermentation Culture

Statistical Optimizing of Medium for Clavulanic Acid Production by Streptomyces Clavuligerus Using Response Surface Methodology